DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Friedlander M, Moore KN, Colombo N. et al.
Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial.
Lancet Oncol 2021;
22 (05) 632-642
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.